← Back to Patent Explorer
US4375468A Expired / Lapsed US ⏱️ 0.0 years remaining

Constant order release aspirin composition and method of treating arthritis

Assignee: Verex Laboratories Inc
•
Filing: 1982-04-08
•
Granted: 1983-03-01
•
Expires: 2002-04-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A constant order release aspirin tablet comprising aspirin, from 0.5 to 10 weight percent of a hydrogenated vegetable oil and from 0.5 to 7 weight percent of a saccharide selected from the group consisting of lactose, sucrose, dextrose fructose and maltose. The aspirin tablet is administered once or twice a day for the chronic treatment of arthritis, and has substantially lessened gastrointestinal side effects.

Inventors

  • 👤 James M. Dunn

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 17:26
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/60; A61K9/00; A61K9/20; A61K9/2004; A61K9/2013; A61K9/2018

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 43 words
A constant order release aspirin tablet comprising aspirin, from 0.5 to 10 weight percent of a hydrogenated vegetable oil, from 0.5 to 7.0 weight percent of a saccharide selected from the group consisting of lactose, sucrose, dextrose, fructose and maltose, and a lubricant.
Claim 2
Dependent Claim 43 words
A constant order release aspirin tablet comprising aspirin, from 0.5 to 10 weight percent of a hydrogenated vegetable oil, from 0.5 to 7.0 weight percent of a saccharide selected from the group consisting of lactose, sucrose, dextrose, fructose and maltose, and a lubricant.
Claim 3
Dependent Claim 16 words
The aspirin tablet of claim 1 wherein said hydrogenated vegetable oil is hydrogenated cotton seed oil.
Claim 4
Dependent Claim 21 words
The aspirin tablet of claim 2 wherein said aspirin tablet includes from 1 to 6 weight percent of hydrogenated cottonseed oil.
Claim 5
Dependent Claim 27 words
The aspirin tablet of claim 1 wherein said tablet additionally comprises from 0.15 to 1.5 weight percent of a cellulose ether, cellulose ester or a combination thereof.
Claim 6
Dependent Claim 15 words
The aspirin tablet of claim 1, 2, 3 or 4 wherein said saccharide is lactose.
Claim 7
Dependent Claim 29 words
A constant order release aspirin tablet comprising aspirin, from 0.5 to 10 weight percent of hydrogenated cottonseed oil, from 0.5 to 7.0 weight percent of lactose and a lubricant.
Claim 8
Dependent Claim 29 words
A constant order release aspirin tablet comprising aspirin, from 0.5 to 10 weight percent of hydrogenated cottonseed oil, from 0.5 to 7.0 weight percent of lactose and a lubricant.
Claim 9
Dependent Claim 45 words
A constant order release aspirin tablet comprising aspirin, from 0.5 to 10 weight percent of hydrogenated cottonseed oil, from 0.5 to 7.0 weight percent of lactose, from 0.15 to 1.5 weight percent of a cellulose ether, cellulose ester or a combination thereof, and a lubricant.
Claim 10
Dependent Claim 45 words
A constant order release aspirin tablet comprising aspirin, from 0.5 to 10 weight percent of hydrogenated cottonseed oil, from 0.5 to 7.0 weight percent of lactose, from 0.15 to 1.5 weight percent of a cellulose ether, cellulose ester or a combination thereof, and a lubricant.
Claim 11
Independent Claim 95 words
A method of producing a control release aspirin tablet comprising the steps of dissolving from 0.5 to 10 weight percent of a hydrogenated vegetable oil in a suitable solvent, admixing said solution with a dry-blended mixture of from 85 to 98 weight percent of aspirin and from 0.5 to 7.0 weight percent of a saccharide selected from the group consisting of lactose, sucrose, dextrose, fructose and maltose to form a wet granulation, drying said wet granulation, sizing said granules, blending said sized granules with a lubricant and thereafter compressing said dried, sized granules into tablets.
Claim 12
Independent Claim 95 words
A method of producing a control release aspirin tablet comprising the steps of dissolving from 0.5 to 10 weight percent of a hydrogenated vegetable oil in a suitable solvent, admixing said solution with a dry-blended mixture of from 85 to 98 weight percent of aspirin and from 0.5 to 7.0 weight percent of a saccharide selected from the group consisting of lactose, sucrose, dextrose, fructose and maltose to form a wet granulation, drying said wet granulation, sizing said granules, blending said sized granules with a lubricant and thereafter compressing said dried, sized granules into tablets.
Claim 13
Dependent Claim 27 words
The method of claim 8 wherein from 0.15 to 1.5 weight percent of a cellulose ether, cellulose ester or a combination thereof is added to said solvent.
Claim 14
Dependent Claim 16 words
The method of claim 8 or 9 wherein said hydrogenated vegetable oil is hydrogenated cottonseed oil.
Claim 15
Dependent Claim 20 words
The method of claim 8, 9 or 10 wherein said solvent is a mixture of methylene chloride and denatured alcohol.
Claim 16
Dependent Claim 13 words
The method of claim 11 wherein said solvent mixture is a 1:1 mixture.
Claim 17
Dependent Claim 13 words
The method of claim 8, 9 or 10 wherein said saccharide is lactose.

References Cited (Backward Citations)

US3384546A Cited
US3627583A Cited
US4079132A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-02-28 1986-08-30 1987-03-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-02-28 1990-08-30 1991-03-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-02-28 1994-08-30 1995-03-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag